Nitric oxide enhances expression of raf kinase inhibitor protein in keratinocytes

Experimental Dermatology
|February 21, 2009
PubMed

Insights

Nitric oxide (NO) treatment elevates raf kinase inhibitor protein (RKIP) expression in human keratinocytes, potentially inhibiting cell proliferation. This finding offers insights into NO

Area of Science:

  • Cell Biology
  • Biochemistry
  • Dermatology

Background:

  • Nitric oxide (NO) is recognized for its role in modulating mammalian cell proliferation and differentiation.
  • Raf kinase inhibitor protein (RKIP) is implicated in cellular signaling pathways.
  • Understanding the interplay between NO and RKIP in keratinocytes is crucial for skin biology.

Discussion:

  • This study investigated the impact of NO on RKIP expression and keratinocyte proliferation.
  • NO donors (SNAP) were used to treat normal human keratinocytes across various concentrations.
  • Measurements included RKIP protein and mRNA levels, cell proliferation, and apoptosis.

Key Insights:

  • Elevated RKIP expression was observed in keratinocytes following NO treatment.
  • This increase in RKIP correlates with NO-mediated inhibition of keratinocyte proliferation.
  • The findings suggest RKIP plays a role in the pathological and physiological effects of NO on keratinocytes.

Outlook:

  • Further research can explore the precise molecular mechanisms linking NO, RKIP, and keratinocyte proliferation.
  • This knowledge may inform therapeutic strategies for skin conditions involving aberrant cell growth.
  • Investigating other cell types and NO-related signaling pathways could broaden the implications.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...